The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression

Mammalian target of rapamycin (mTOR) signaling is a critical pathway in the biology of acute myeloid leukemia (AML). Proviral integration site for moloney murine leukemia virus (PIM) serine/threonine kinase signaling takes part in various pathways exerting tumorigenic properties. We hypothesized tha...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Harada, Masako, Benito, Juliana, Yamamoto, Shinichi, Kaur, Surinder, Arslan, Dirim, Ramirez, Santiago, Jacamo, Rodrigo, Platanias, Leonidas, Matsushita, Hiromichi, Fujimura, Tsutomu, Kazuno, Saiko, Kojima, Kensuke, Tabe, Yoko, Konopleva, Marina
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2015
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741975/
https://ncbi.nlm.nih.gov/pubmed/26473447
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi